Case report
Tocilizumab in a Patient With Tophaceous Gout Resistant to Treatment
Tocilizumab en paciente con gota tofácea severa refractaria al tratamiento
Jessica L. Pinto, Gloria E. Mora, Daniel G. Fernández-Avila
, Juan M. Gutiérrez, María C. Díaz, Grupo Javeriano de Investigación en Enfermedades Reumáticas
Unidad de Reumatología, Departamento de Medicina Interna, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia
Read
8511
Timeswas read the article
2769
Total PDF
5742
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 4 | 3 | 7 |
| 2025 5 | 122 | 78 | 200 |
| 2025 4 | 103 | 45 | 148 |
| 2025 3 | 81 | 36 | 117 |
| 2025 2 | 84 | 43 | 127 |
| 2025 1 | 63 | 39 | 102 |
| 2024 12 | 45 | 36 | 81 |
| 2024 11 | 80 | 71 | 151 |
| 2024 10 | 67 | 52 | 119 |
| 2024 9 | 61 | 25 | 86 |
| 2024 8 | 76 | 37 | 113 |
| 2024 7 | 49 | 33 | 82 |
| 2024 6 | 65 | 26 | 91 |
| 2024 5 | 89 | 37 | 126 |
| 2024 4 | 45 | 18 | 63 |
| 2024 3 | 51 | 37 | 88 |
| 2024 2 | 33 | 16 | 49 |
| 2024 1 | 43 | 22 | 65 |
| 2023 12 | 32 | 37 | 69 |
| 2023 11 | 27 | 18 | 45 |
| 2023 10 | 45 | 31 | 76 |
| 2023 9 | 73 | 30 | 103 |
| 2023 8 | 27 | 23 | 50 |
| 2023 7 | 32 | 22 | 54 |
| 2023 6 | 32 | 42 | 74 |
| 2023 5 | 41 | 21 | 62 |
| 2023 4 | 46 | 14 | 60 |
| 2023 3 | 55 | 28 | 83 |
| 2023 2 | 39 | 33 | 72 |
| 2023 1 | 41 | 19 | 60 |
| 2022 12 | 47 | 30 | 77 |
| 2022 11 | 56 | 36 | 92 |
| 2022 10 | 59 | 22 | 81 |
| 2022 9 | 54 | 35 | 89 |
| 2022 8 | 75 | 40 | 115 |
| 2022 7 | 50 | 55 | 105 |
| 2022 6 | 36 | 34 | 70 |
| 2022 5 | 51 | 43 | 94 |
| 2022 4 | 66 | 47 | 113 |
| 2022 3 | 53 | 45 | 98 |
| 2022 2 | 59 | 46 | 105 |
| 2022 1 | 37 | 40 | 77 |
| 2021 12 | 30 | 41 | 71 |
| 2021 11 | 39 | 48 | 87 |
| 2021 10 | 54 | 44 | 98 |
| 2021 9 | 51 | 44 | 95 |
| 2021 8 | 44 | 51 | 95 |
| 2021 7 | 29 | 42 | 71 |
| 2021 6 | 43 | 48 | 91 |
| 2021 5 | 54 | 51 | 105 |
| 2021 4 | 137 | 92 | 229 |
| 2021 3 | 85 | 33 | 118 |
| 2021 2 | 71 | 28 | 99 |
| 2021 1 | 44 | 27 | 71 |
| 2020 12 | 33 | 26 | 59 |
| 2020 11 | 48 | 16 | 64 |
| 2020 10 | 34 | 18 | 52 |
| 2020 9 | 52 | 38 | 90 |
| 2020 8 | 37 | 19 | 56 |
| 2020 7 | 36 | 15 | 51 |
| 2020 6 | 31 | 21 | 52 |
| 2020 5 | 23 | 19 | 42 |
| 2020 4 | 37 | 29 | 66 |
| 2020 3 | 37 | 4 | 41 |
| 2020 2 | 1 | 0 | 1 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 1 | 0 | 1 |
| 2019 3 | 1 | 0 | 1 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 2 | 0 | 2 |
| 2018 5 | 4 | 1 | 5 |
| 2018 4 | 45 | 11 | 56 |
| 2018 3 | 53 | 7 | 60 |
| 2018 2 | 36 | 10 | 46 |
| 2018 1 | 21 | 3 | 24 |
| 2017 12 | 34 | 7 | 41 |
| 2017 11 | 32 | 11 | 43 |
| 2017 10 | 31 | 3 | 34 |
| 2017 9 | 32 | 18 | 50 |
| 2017 8 | 40 | 10 | 50 |
| 2017 7 | 28 | 8 | 36 |
| 2017 6 | 49 | 7 | 56 |
| 2017 5 | 54 | 18 | 72 |
| 2017 4 | 35 | 13 | 48 |
| 2017 3 | 38 | 4 | 42 |
| 2017 2 | 24 | 5 | 29 |
| 2017 1 | 33 | 3 | 36 |
| 2016 12 | 67 | 15 | 82 |
| 2016 11 | 39 | 4 | 43 |
| 2016 10 | 74 | 8 | 82 |
| 2016 9 | 80 | 5 | 85 |
| 2016 8 | 84 | 6 | 90 |
| 2016 7 | 36 | 8 | 44 |
| 2016 6 | 1 | 0 | 1 |
| 2016 5 | 1 | 0 | 1 |
| 2016 4 | 1 | 0 | 1 |
| 2016 3 | 4 | 13 | 17 |
| 2016 2 | 1 | 0 | 1 |
| 2016 1 | 2 | 0 | 2 |
| 2015 12 | 3 | 0 | 3 |
| 2015 10 | 2 | 11 | 13 |
| 2015 9 | 2 | 13 | 15 |
| 2015 8 | 3 | 0 | 3 |
| 2015 7 | 20 | 6 | 26 |
| 2015 6 | 39 | 6 | 45 |
| 2015 5 | 54 | 6 | 60 |
| 2015 4 | 49 | 12 | 61 |
| 2015 3 | 59 | 7 | 66 |
| 2015 2 | 50 | 6 | 56 |
| 2015 1 | 46 | 9 | 55 |
| 2014 12 | 63 | 10 | 73 |
| 2014 11 | 47 | 10 | 57 |
| 2014 10 | 44 | 14 | 58 |
| 2014 9 | 48 | 11 | 59 |
| 2014 8 | 54 | 16 | 70 |
| 2014 7 | 56 | 20 | 76 |
| 2014 6 | 62 | 12 | 74 |
| 2014 5 | 85 | 15 | 100 |
| 2014 4 | 61 | 8 | 69 |
| 2014 3 | 64 | 19 | 83 |
| 2014 2 | 40 | 11 | 51 |
| 2014 1 | 46 | 18 | 64 |
| 2013 12 | 56 | 10 | 66 |
| 2013 11 | 44 | 11 | 55 |
| 2013 10 | 48 | 11 | 59 |
| 2013 9 | 38 | 9 | 47 |
| 2013 8 | 55 | 31 | 86 |
| 2013 7 | 107 | 28 | 135 |
| 2013 6 | 51 | 24 | 75 |
| 2013 5 | 10 | 8 | 18 |
Show all
